---
title: "Adial Pharmaceuticals surges 16%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303427362.md"
description: "Adial Pharmaceuticals rose 16.17% to US$4.310. Up 176.28% over six months and down 21.64% YTD."
datetime: "2026-10-28T17:46:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303427362.md)
  - [en](https://longbridge.com/en/news/303427362.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303427362.md)
generator: "portal-rs"
---

# Adial Pharmaceuticals surges 16%

Adial Pharmaceuticals (ADIL.US) surged more than **16%** during regular trading to **$4.31**.

The stock is up 43.67% over the past ten sessions, up 176.28% over the past six months and down 21.64% year to date. It sits 229.01% above its 52-week low of US$1.310. The intraday swing reached 13.21%.

The Nasdaq Composite is down 0.86% over the past five sessions and up 13.90% year to date.

The company filed an amended quarterly financial report for the period ended June 30, 2026, via EDGAR on Oct. 21, 2026.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [ADIL.US](https://longbridge.com/en/quote/ADIL.US.md)
- [AZR.US](https://longbridge.com/en/quote/AZR.US.md)

## Related News & Research

- [Adial Pharmaceuticals delays shareholder meeting vote on proposals 3-6 to Oct. 15 pending Nasdaq approval](https://longbridge.com/en/news/300824661.md)
- [Adial Pharmaceuticals Files Initial Beneficial Ownership Statement for CFO Vassiliki Economides](https://longbridge.com/en/news/303813186.md)
- [BUZZ-Street View: Nvidia's AI story intact despite uncertainty at top](https://longbridge.com/en/news/305945171.md)
- [INSTANT VIEW-Nvidia earnings beat estimates; attention turns to call](https://longbridge.com/en/news/305875718.md)
- [Will Upper Stage Recovery Change SpaceX's (SPCX) Narrative](https://longbridge.com/en/news/305914563.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**